BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 18716108)

  • 1. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
    Ma X; Samir AE; Holalkere NS; Sahani DV
    AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
    Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
    Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging.
    Sultana S; Awai K; Nakayama Y; Nakaura T; Liu D; Hatemura M; Funama Y; Morishita S; Yamashita Y
    Radiology; 2007 Apr; 243(1):140-7. PubMed ID: 17329690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal dose of contrast medium for depiction of hypervascular HCC on dynamic MDCT.
    Fujigai T; Kumano S; Okada M; Hyodo T; Imaoka I; Yagyu Y; Ashikaga R; Ishii K; Murakami T
    Eur J Radiol; 2012 Nov; 81(11):2978-83. PubMed ID: 22305012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma.
    Kanematsu M; Goshima S; Kondo H; Nishibori H; Kato H; Yokoyama R; Miyoshi T; Hoshi H; Onozuka M; Moriyama N
    J Comput Assist Tomogr; 2005; 29(2):195-201. PubMed ID: 15772536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Miyoshi T; Nishibori H; Kato H; Hoshi H; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2006 Jul; 187(1):W25-32. PubMed ID: 16794136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination.
    Kim MJ; Choi JY; Lim JS; Kim JY; Kim JH; Oh YT; Yoo EH; Chung JJ; Kim KW
    AJR Am J Roentgenol; 2006 Jul; 187(1):198-206. PubMed ID: 16794177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
    Ichikawa T; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Yoshikawa S; Shiosakai K; Hayakawa A; Awai K; Yoshimitsu K; Yamashita Y
    Acad Radiol; 2013 Sep; 20(9):1130-6. PubMed ID: 23931427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
    Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
    Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDCT of the pancreas: optimizing scanning delay with a bolus-tracking technique for pancreatic, peripancreatic vascular, and hepatic contrast enhancement.
    Kondo H; Kanematsu M; Goshima S; Miyoshi T; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    AJR Am J Roentgenol; 2007 Mar; 188(3):751-6. PubMed ID: 17312064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis of hepatocellular carcinoma under multislice spiral CT plain scan and enhanced scan.
    Ma AD; Zhang Y; Xue Z; Li K
    J Biol Regul Homeost Agents; 2015; 29(4):895-903. PubMed ID: 26753654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of optimal timing of arterial phase imaging for the detection of hypervascular hepatocellular carcinoma by using triple arterial phase imaging with multidetector-row helical computed tomography.
    Murakami T; Kim T; Kawata S; Kanematsu M; Federle MP; Hori M; Okada A; Kumano S; Sugihara E; Tomoda K; Nakamura H
    Invest Radiol; 2003 Aug; 38(8):497-503. PubMed ID: 12874516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
    Awai K; Takada K; Onishi H; Hori S
    Radiology; 2002 Sep; 224(3):757-63. PubMed ID: 12202710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT.
    Yanaga Y; Awai K; Nakayama Y; Nakaura T; Tamura Y; Funama Y; Aoyama M; Asada N; Yamashita Y
    Radiat Med; 2007 Jul; 25(6):278-88. PubMed ID: 17634881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hypervascular hepatocellular carcinoma with multidetector-row CT: single arterial-phase imaging with computer-assisted automatic bolus-tracking technique compared with double arterial-phase imaging.
    Kitamura T; Ichikawa T; Erturk SM; Nakajima H; Sou H; Araki T; Okada S; Enomoto N
    J Comput Assist Tomogr; 2008; 32(5):724-9. PubMed ID: 18830101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT.
    Yanaga Y; Awai K; Nakaura T; Namimoto T; Oda S; Funama Y; Yamashita Y
    AJR Am J Roentgenol; 2008 Apr; 190(4):1003-9. PubMed ID: 18356448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver: comparison of different concentrations of contrast material with multi-detector row helical CT--a prospective randomized study.
    Sofue K; Tsurusaki M; Kawasaki R; Fujii M; Sugimura K
    Eur J Radiol; 2011 Dec; 80(3):e237-42. PubMed ID: 21067880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of early enhancement of hypervascular hepatocellular carcinoma using single breath-hold 3D pixel shift dynamic subtraction MDCT.
    Nakaura T; Awai K; Yanaga Y; Nakayama Y; Oda S; Funama Y; Yamashita Y
    AJR Am J Roentgenol; 2008 Jan; 190(1):W13-8. PubMed ID: 18094267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT.
    Murakami T; Kim T; Takamura M; Hori M; Takahashi S; Federle MP; Tsuda K; Osuga K; Kawata S; Nakamura H; Kudo M
    Radiology; 2001 Mar; 218(3):763-7. PubMed ID: 11230652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Okada A; Sugiura T; Tomoda K; Narumi Y; Nakamura H
    J Comput Assist Tomogr; 2002; 26(6):981-7. PubMed ID: 12488747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.